Friday, July 3, 2026

#biotech

12 articles

Novo Nordisk Exits Internal Parkinson's Unit, Licenses Program to AI Partner Cellular Intelligence

Healthcare & Biotech

Novo Nordisk Exits Internal Parkinson's Unit, Licenses Program to AI Partner Cellular Intelligence

Salvado•Jun 25, 2026

H2 2026 FDA Decision Cluster Forces Biotech Repricing Across ADCs and Cell Therapies

Biotech Investment

H2 2026 FDA Decision Cluster Forces Biotech Repricing Across ADCs and Cell Therapies

Salvado•Jun 17, 2026

Novo Nordisk Outsources Parkinson's R&D to AI Partner as Big Pharma Drops Vertical Integration

Corporate Strategy

Novo Nordisk Outsources Parkinson's R&D to AI Partner as Big Pharma Drops Vertical Integration

Salvado•Jun 9, 2026

GRAIL Stock Falls 20% After NHS Cancer Detection Trial Misses Primary Endpoint

Biotech & Healthcare Companies

GRAIL Stock Falls 20% After NHS Cancer Detection Trial Misses Primary Endpoint

Salvado•May 27, 2026

ADC Combination Trials Converge on 2026–2027 Regulatory Window, Concentrating Biotech Binary Risk

Biotech Investment

ADC Combination Trials Converge on 2026–2027 Regulatory Window, Concentrating Biotech Binary Risk

Salvado•May 27, 2026

Vepdegestrant's 5-Month PFS Anchors Rigel-Arvinas-Pfizer Deal as Three PDUFA Dates Cluster in 2026

Biotech Dealmaking

Vepdegestrant's 5-Month PFS Anchors Rigel-Arvinas-Pfizer Deal as Three PDUFA Dates Cluster in 2026

Salvado•May 17, 2026

Novo Nordisk's 24.9% Stock Surge Validates Pharma's Pivot From Internal R&D to AI Partnerships

Pharma & Healthcare

Novo Nordisk's 24.9% Stock Surge Validates Pharma's Pivot From Internal R&D to AI Partnerships

Salvado•May 13, 2026

Alopecia Areata Market Poised for Expansion by 2036 as Novel Drug Classes Enter Pipeline

Pharmaceutical Markets

Alopecia Areata Market Poised for Expansion by 2036 as Novel Drug Classes Enter Pipeline

Salvado•Apr 26, 2026

NVIDIA Partners with Eli Lilly, Thermo Fisher to Build AI Drug Discovery Infrastructure

Corporate Strategy

NVIDIA Partners with Eli Lilly, Thermo Fisher to Build AI Drug Discovery Infrastructure

Salvado•Apr 13, 2026

NVIDIA Expands Biotech AI Infrastructure Through Partnerships with Thermo Fisher and Eli Lilly

Corporate Strategy

NVIDIA Expands Biotech AI Infrastructure Through Partnerships with Thermo Fisher and Eli Lilly

Salvado•Mar 25, 2026

Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors

Healthcare Finance

Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors

ViaNews Editorial Team (Finance)•Feb 18, 2026

Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle

Four Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research Cycle

ViaNews Editorial Team (Finance)•Feb 15, 2026